• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ST14 基因相关甲基化状态作为乳腺癌生存和激素受体阳性的预测因子。

Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast Cancer.

机构信息

Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, No. 325, Chengong Rd., Sec. 2, Neihu, Taipei, 114, Taiwan.

Department of Radiation Oncology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.

出版信息

BMC Cancer. 2021 Aug 21;21(1):945. doi: 10.1186/s12885-021-08645-3.

DOI:10.1186/s12885-021-08645-3
PMID:34418985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8380334/
Abstract

BACKGROUND

Genomic profiles of specific gene sets have been established to guide personalized treatment and prognosis for patients with breast cancer (BC). However, epigenomic information has not yet been applied in a clinical setting. ST14 encodes matriptase, a proteinase that is widely expressed in BC with reported prognostic value.

METHODS

In this present study, we evaluated the effect of ST14 DNA methylation (DNAm) on overall survival (OS) of patients with BC as a representative example to promote the use of the epigenome in clinical decisions. We analyzed publicly available genomic and epigenomic data from 1361 BC patients. Methylation was characterized by the β-value from CpG probes based on sequencing with the Illumina Human 450 K platform.

RESULTS

A high mean DNAm (β > 0.6779) across 34 CpG probes for ST14, as the gene-associated methylation (GAM) pattern, was associated with a longer OS after adjusting age, stage, histology and molecular features in Cox model (p value < 0.001). A high GAM status was also associated with a higher XBP1 expression level and higher proportion of hormone-positive BC (p value < 0.001). Pathway analysis revealed that altered GAM was related to matrisome-associated pathway.

CONCLUSIONS

Here we show the potential role of ST14 DNAm in BC prognosis and warrant further study.

摘要

背景

已经建立了特定基因集的基因组图谱,以指导乳腺癌(BC)患者的个性化治疗和预后。然而,表观基因组信息尚未在临床环境中应用。ST14 编码组织蛋白酶,一种在 BC 中广泛表达的蛋白水解酶,具有报道的预后价值。

方法

在本研究中,我们评估了 ST14 DNA 甲基化(DNAm)对 BC 患者总生存期(OS)的影响,作为促进将表观基因组应用于临床决策的代表例子。我们分析了来自 1361 名 BC 患者的公开可用基因组和表观基因组数据。甲基化通过基于 Illumina Human 450K 平台测序的 CpG 探针的β值进行表征。

结果

34 个 CpG 探针中 ST14 的平均 DNAm(β>0.6779)较高,作为基因相关甲基化(GAM)模式,在 Cox 模型中调整年龄、分期、组织学和分子特征后与更长的 OS 相关(p 值<0.001)。高 GAM 状态也与 XBP1 表达水平更高和激素阳性 BC 的比例更高相关(p 值<0.001)。通路分析显示,改变的 GAM 与基质体相关通路有关。

结论

我们在这里显示了 ST14 DNAm 在 BC 预后中的潜在作用,并需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/617341242d3c/12885_2021_8645_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/a1c2ae655df0/12885_2021_8645_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/1722d4e2f282/12885_2021_8645_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/5102cb468cbe/12885_2021_8645_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/c7382eb5e20c/12885_2021_8645_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/f6bd387429d4/12885_2021_8645_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/617341242d3c/12885_2021_8645_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/a1c2ae655df0/12885_2021_8645_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/1722d4e2f282/12885_2021_8645_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/5102cb468cbe/12885_2021_8645_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/c7382eb5e20c/12885_2021_8645_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/f6bd387429d4/12885_2021_8645_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98a2/8380334/617341242d3c/12885_2021_8645_Fig6_HTML.jpg

相似文献

1
Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast Cancer.ST14 基因相关甲基化状态作为乳腺癌生存和激素受体阳性的预测因子。
BMC Cancer. 2021 Aug 21;21(1):945. doi: 10.1186/s12885-021-08645-3.
2
Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer.肿瘤抑制因子14(ST14)/丝氨酸蛋白酶14(Prss14)表达分析对雌激素受体阴性乳腺癌预后及治疗的影响
Oncotarget. 2016 Jun 7;7(23):34643-63. doi: 10.18632/oncotarget.9155.
3
Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer.肌氨酸病毒抗性蛋白 1(MX1)是浸润性乳腺癌不良预后的独立预测因子。
Breast Cancer Res Treat. 2020 Jun;181(3):541-551. doi: 10.1007/s10549-020-05646-x. Epub 2020 Apr 29.
4
DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.DNA甲基化模式可预估具有相同受体亚型的乳腺癌的不同结局。
PLoS One. 2015 Nov 9;10(11):e0142279. doi: 10.1371/journal.pone.0142279. eCollection 2015.
5
BRCA1 Promoter Methylation and Expression - Associations with ER+, PR+ and HER2+ Subtypes of Breast Carcinoma.BRCA1启动子甲基化与表达——与雌激素受体阳性、孕激素受体阳性及人表皮生长因子受体2阳性乳腺癌亚型的关联
Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3293-3299. doi: 10.22034/APJCP.2017.18.12.3293.
6
PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement.PI3K/AKT 信号通路在乳腺癌分子分型和淋巴结受累中的作用。
Dis Markers. 2019 Nov 6;2019:7832376. doi: 10.1155/2019/7832376. eCollection 2019.
7
Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients.RASSF1A 的异常甲基化与突尼斯乳腺癌患者的不良生存相关。
J Cancer Res Clin Oncol. 2010 Feb;136(2):203-10. doi: 10.1007/s00432-009-0649-6. Epub 2009 Aug 6.
8
Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.在雌激素受体阳性乳腺癌患者中,区域特异性糖皮质激素受体启动子甲基化具有阳性和阴性预后价值。
Clin Epigenetics. 2019 Nov 1;11(1):155. doi: 10.1186/s13148-019-0750-x.
9
Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.CDH1在乳腺癌中的临床病理意义及潜在药物靶点:一项荟萃分析与文献综述
Drug Des Devel Ther. 2015 Sep 18;9:5277-85. doi: 10.2147/DDDT.S86929. eCollection 2015.
10
Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.继发性乳腺癌的表观基因组和转录组特征。
Ann Surg Oncol. 2018 Oct;25(10):3082-3087. doi: 10.1245/s10434-018-6582-7. Epub 2018 Jun 28.

引用本文的文献

1
Unveiling diagnostic biomarkers and therapeutic targets in lung adenocarcinoma using bioinformatics and experimental validation.利用生物信息学和实验验证揭示肺腺癌的诊断生物标志物和治疗靶点。
Sci Rep. 2025 Jul 2;15(1):22893. doi: 10.1038/s41598-025-05227-2.
2
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine.乳腺癌研究中反映出的全基因组甲基化状态与长链非编码RNA表达之间尚未充分探索的相互关系:在3P医学框架下对疾病管理的潜在影响
EPMA J. 2023 May 22;14(2):249-273. doi: 10.1007/s13167-023-00323-7. eCollection 2023 Jun.
3

本文引用的文献

1
Promoter DNA Hypermethylation and Paradoxical Gene Activation.启动子 DNA 高甲基化与反常基因激活。
Trends Cancer. 2020 May;6(5):392-406. doi: 10.1016/j.trecan.2020.02.007. Epub 2020 Mar 4.
2
MGMT Status as a Clinical Biomarker in Glioblastoma.MGMT 状态作为胶质母细胞瘤的临床生物标志物。
Trends Cancer. 2020 May;6(5):380-391. doi: 10.1016/j.trecan.2020.02.010. Epub 2020 Mar 27.
3
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.乳腺癌中 DNA 甲基化的研究路线图确定了新的预后生物标志物。
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool.
CRISPR/Cas9 在癌症治疗中的应用:一种开拓性的基因组编辑工具。
Cell Mol Biol Lett. 2022 May 4;27(1):35. doi: 10.1186/s11658-022-00336-6.
4
Transcriptome-wide analyses of adipose tissue in outbred rats reveal genetic regulatory mechanisms relevant for human obesity.外群大鼠脂肪组织的转录组分析揭示了与人类肥胖相关的遗传调控机制。
Physiol Genomics. 2022 Jun 1;54(6):206-219. doi: 10.1152/physiolgenomics.00172.2021. Epub 2022 Apr 25.
BMC Cancer. 2019 Mar 12;19(1):219. doi: 10.1186/s12885-019-5403-0.
4
The role of neurologists in tackling the opioid epidemic.神经科医生在应对阿片类药物流行中的作用。
Nat Rev Neurol. 2019 May;15(5):301-305. doi: 10.1038/s41582-019-0146-8.
5
Estrogen receptor-α regulation of microRNA-590 targets FAM171A1-a modifier of breast cancer invasiveness.雌激素受体-α对微小RNA-590靶标FAM171A1的调控——一种乳腺癌侵袭性的调节因子。
Oncogenesis. 2019 Jan 9;8(1):5. doi: 10.1038/s41389-018-0113-z.
6
BioJupies: Automated Generation of Interactive Notebooks for RNA-Seq Data Analysis in the Cloud.BioJupies:在云端自动生成用于 RNA-Seq 数据分析的交互式笔记本。
Cell Syst. 2018 Nov 28;7(5):556-561.e3. doi: 10.1016/j.cels.2018.10.007. Epub 2018 Nov 14.
7
DNA methylation in breast cancers: Differences based on estrogen receptor status and recurrence.乳腺癌中的 DNA 甲基化:基于雌激素受体状态和复发的差异。
J Cell Biochem. 2019 Jan;120(1):738-755. doi: 10.1002/jcb.27431. Epub 2018 Sep 19.
8
Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer.基因体 CpG 岛的超甲基化预示着肝癌中功能性致癌基因的高剂量。
Nat Commun. 2018 Aug 8;9(1):3164. doi: 10.1038/s41467-018-05550-5.
9
XBP1 promotes tumor invasion and is associated with poor prognosis in oral squamous cell carcinoma.XBP1 促进肿瘤侵袭,与口腔鳞状细胞癌的不良预后相关。
Oncol Rep. 2018 Aug;40(2):988-998. doi: 10.3892/or.2018.6498. Epub 2018 Jun 18.
10
Epigenetic landscape change analysis during human EMT sheds light on a key EMT mediator TRIM29.人类上皮-间质转化过程中的表观遗传景观变化分析揭示了关键的上皮-间质转化介质TRIM29。
Oncotarget. 2017 Oct 9;8(58):98322-98335. doi: 10.18632/oncotarget.21681. eCollection 2017 Nov 17.